Vertex Pharmaceuticals ( VRTX 5.31%) just snagged its second U.S. Food and Drug Administration (FDA) approval in only 41 days. On Dec. 20, 2024, the FDA gave a thumbs-up to Alyftrek in treating cystic ...

Short FDX slightly under 265.57, target n/a, stop loss @ 266.34 Check the time stamp on this data. Updated AI-Generated ...

We recently compiled a list of the 10 Large-Cap Stocks Insiders Are Buying Recently. In this article, we are going to take a look at where FedEx Corporation (NYSE:FDX) stands against the other ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...

JPMorgan lowered the firm’s price target on UPS (UPS) to $120 from $135 and keeps a Neutral rating on the shares post the Q4 report. The ...

Stifel analysts adjusted their outlook on UPS (NYSE:UPS) by reducing the price target to $145, down from the previous $153, while continuing to endorse the stock with a Buy rating. The revision ...

United Parcel Service struggles with declining revenue and profit margins, with a significant stock drop due to strategic ...

Investing.com -- FedEx (NYSE: FDX) stock tumbled 3.5% today after rival United Parcel Service Inc. (NYSE: UPS) released a revenue forecast that fell short of market expectations, signaling weaker ...

In the most recent trading session, FedEx (FDX) closed at $275.06, indicating a -1.29% shift from the previous trading day.